Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection

•Documents stimulant-associated leukocyte gene expression in treated HIV infection.•Elevated tumor necrosis factor – alpha (TNF-α) levels in recent stimulant users.•Stimulant use may contribute to HIV persistence and residual immune dysregulation. Stimulant use may accelerate HIV disease progression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain, behavior, and immunity behavior, and immunity, 2018-07, Vol.71, p.108-115
Hauptverfasser: Carrico, Adam W., Flentje, Annesa, Kober, Kord, Lee, Sulggi, Hunt, Peter, Riley, Elise D., Shoptaw, Steven, Flowers, Elena, Dilworth, Samantha E., Pahwa, Savita, Aouizerat, Bradley E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Documents stimulant-associated leukocyte gene expression in treated HIV infection.•Elevated tumor necrosis factor – alpha (TNF-α) levels in recent stimulant users.•Stimulant use may contribute to HIV persistence and residual immune dysregulation. Stimulant use may accelerate HIV disease progression through biological and behavioral pathways. However, scant research with treated HIV-positive persons has examined stimulant-associated alterations in pathophysiologic processes relevant to HIV pathogenesis. In a sample of 55 HIV-positive, methamphetamine-using sexual minority men with a viral load less than 200 copies/mL, we conducted RNA sequencing to examine patterns of leukocyte gene expression in participants who had a urine sample that was reactive for stimulants (n = 27) as compared to those who tested non-reactive (n = 28). Results indicated differential expression of 32 genes and perturbation of 168 pathways in recent stimulant users. We observed statistically significant differential expression of single genes previously associated with HIV latency, cell cycle regulation, and immune activation in recent stimulant users (false discovery rate p 
ISSN:0889-1591
1090-2139
DOI:10.1016/j.bbi.2018.04.004